Mikatax Amikacin Sulphate Injection IP, 500 mg/ 2ml

Description

Mikatax Amikacin Sulphate Injection IP contains 500 mg of amikacin sulfate per 2 ml of solution. This antibiotic is used to treat severe bacterial infections that may not respond to other antibiotics. It belongs to the aminoglycoside class and works by inhibiting bacterial protein synthesis, thereby halting bacterial growth and effectively treating infections.

When administered, Mikatax Amikacin Sulphate Injection IP is typically given intravenously (IV) or intramuscularly (IM) under the supervision of a healthcare professional. Common side effects may include nephrotoxicity (kidney damage), ototoxicity (hearing loss), gastrointestinal disturbances, and injection site reactions. Serious adverse effects such as allergic reactions and neurological effects can also occur, necessitating close monitoring during treatment.

It’s important to store Mikatax Amikacin Sulphate Injection IP at room temperature, away from light and moisture, and to check the expiry date before use. For detailed dosing instructions and personalized medical advice, consult with your healthcare provider.

Uses: Amikacin sulfate injection is indicated for infections where other antibiotics may not be effective or suitable. It is commonly used in hospital settings for serious conditions like:

• Septicemia (bloodstream infections)
• Respiratory tract infections
• Urinary tract infections
• Bone and joint infections
• Intra-abdominal infections
• Skin and soft tissue infections

Side Effects: Like all medications, Mikatax Amikacin Sulphate Injection IP can cause side effects. Common side effects include:

• Nephrotoxicity: Kidney damage, which can be monitored through blood tests.
• Ototoxicity: Hearing loss or balance issues, particularly with prolonged use or high doses.
• Gastrointestinal disturbances: Nausea, vomiting, diarrhea.
• Injection site reactions: Pain, redness, or swelling at the injection site.

Serious side effects are rare but may include allergic reactions, neurological effects, and potentially severe kidney or hearing problems. Patients receiving this medication should be monitored closely by healthcare professionals for any signs of adverse effects.

For specific guidance on dosage, administration, and management of side effects, it’s essential to consult with a healthcare provider or pharmacist.